| Pharmaceutical active ingredients: |
| Caramiphen EdisilatePhenylpropanolamine Hydrochloride |
| Available forms, composition and doses of Ordrine AT Extended Release: |
| N / A |
| Ordrine AT Extended Release medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01BA51 - Phenylpropanolamine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Eon Labs |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Zapto Co | Captopril; Hydrochlorothiazide | Aspen Pharmacare |
| Zidepril | Captopril; Hydrochlorothiazide | Minerva Pharmaceutical |
| Captocomp | Captopril; Verapamil Hydrochloride | Ebewe |
| Veracapt | Captopril; Verapamil Hydrochloride | Ebewe |
| Tuss-Ornade | Caramiphen Edisilate; Chlorpheniramine Maleate; Phenylpropanolamine Hydrochloride | GlaxoSmithKline |
| Rescaps-D SR | Caramiphen Edisilate; Phenylpropanolamine Hydrochloride | Novartis |
| Tuss-Allergine Modified TD | Caramiphen Edisilate; Phenylpropanolamine Hydrochloride | Watson Pharmaceuticals |
| Tuss-Genade Modified | Caramiphen Edisilate; Phenylpropanolamine Hydrochloride | IVAX |
| Tussogest Extended-Release | Caramiphen Edisilate; Phenylpropanolamine Hydrochloride | The Harvard Drug Group |
| Carum Carvi | Caraway | Boiron |